# Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque Psoriasis

> **NCT01072383** · PHASE2 · COMPLETED · sponsor: **Biotest** · enrollment: 49 (actual)

## Conditions studied

- Psoriasis Vulgaris

## Interventions

- **DRUG:** BT061
- **DRUG:** placebo treatment

## Key facts

- **NCT ID:** NCT01072383
- **Lead sponsor:** Biotest
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2011-06
- **Final completion:** 2011-08
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2012-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01072383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01072383, "Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque Psoriasis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01072383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*